Articles
PagSeguro (PAGS): Buy the Yield and Durable Growth - Entry 9.2–9.9, Stop 8.0, Targets 12.5 / 15.0
Brazil-focused fintech offering double-digit growth optionality with a near 5% cash yield — tactical long for a 6–12 month position.
PagSeguro combines a sticky SME payments franchise with an expanding digital-account ecosystem. The stock trades around $9.64 with an annualized cash ...
Understanding and Reversing Social Security Early Claim Penalties
Exploring the limited avenues for retirees to recover reduced benefits after early Social Security claims
Many retirees face confusion about the implications of claiming Social Security benefits before reaching full retirement age (FRA). Contrary to some b...
Buffalo Bills Prepare to Close Chapter on Iconic Stadium as New Venue Awaits
Highmark Stadium's final days invoke reflection among players, staff, and fans ahead of the franchise’s next era
As the Buffalo Bills approach their final regular-season game at Highmark Stadium, affectionately known as 'The Ralph,' longtime insiders and fans ref...
Rigel Pharmaceuticals: Building a 2026 Playbook — Buy on Discipline, Size for Volatility
Revenue inflection, cash strength, and a clearer commercial path make RIGL a tactical long — trade plan included.
Rigel (RIGL) has moved from a cash-burning developer to a profitable, cash-rich company in 2025 thanks to accelerating revenues and expanding gross ma...
TMC: A High-Risk Long on a Potential U.S.-Backed Critical‑Mineral Story
Small position, event-driven trade: buy the policy/permit optionality — manage the balance-sheet and permitting risks tightly.
TMC the metals Co. is a pre-revenue deep-sea nodules explorer with a highly volatile share price and a narrative increasingly tied to U.S. critical‑...
Finnish Authorities Detain Cargo Vessel Linked to Undersea Telecom Cable Disruption in Gulf of Finland
Investigation underway as Finland and Estonia collaborate on damaged submarine communication infrastructure
Finnish law enforcement has taken control of the Russian-flagged cargo ship Fitburg, implicating it in damage to submarine telecommunications cables c...
Finnish Authorities Detain Russian Vessel Over Suspected Damage to Undersea Telecom Infrastructure
Investigation Underway After Cable Disruption in Gulf of Finland Impacts Estonian-Finnish Network
Finnish law enforcement have taken control of a Russian-flagged cargo ship after suspicious damage to an undersea telecommunications cable connecting ...
Navigating Social Security Changes and Considerations Entering 2026
Understanding Benefit Adjustments, Eligibility Timing, and Program Stability for Effective Financial Planning
As 2026 begins, it is essential for both current and prospective Social Security beneficiaries to reassess their financial situations with an emphasis...
Merck: Cheap, Cash-Generating Pharma Franchise — A Tactical Long with Clear Entries and Stops
Operational cash flow, steady dividends and a deep pipeline cushion a post-Keytruda transition; valuation looks stretched to the downside.
Merck is trading at a low multiple by the simple math of recent quarter results annualized. The company produced $17.3B in revenue and $5.79B in net i...
Cryptocurrency Forecast: XRP and Shiba Inu Poised for Significant Declines in 2026
Structural challenges and market dynamics suggest potential 50% or greater drops for two major tokens
The cryptocurrency sector, valued at $3.5 trillion entering 2025, has seen its total market capitalization diminish to below $3 trillion amid declines...
Strategy Optimization through Trade Journaling: Building a Feedback Loop for Consistent Stock Trading Improvement
For beginner and intermediate traders seeking to leverage trade journaling as a tool to refine strategies, enhance discipline, and manage risk systematically
Trade journaling is a powerful method for traders to capture detailed records of their trades, analyze performance critically, and implement continuou...
Why Viking Could Be a Speculative Play on the Oral GLP-1 Frenzy
Cash-rich balance sheet + heavy R&D = takeover optionality in a market that prizes oral metabolic assets
Viking Therapeutics (VKTX) is a paradox: no revenues, heavy R&D (Q3 2025 R&D $89.95M), and a balance sheet with large current assets ($738.7M). The ma...